ENSG
Ensign GroupCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
Ensign exited 2025 with record occupancy, strong skilled-day growth, 2026 guidance calling for another year of double-digit EPS growth, and additional February 2026 acquisitions that expand both the operating footprint and Standard Bearer real-estate base [#8-K-2026-02-04][#PR-2026-02-04][#PR-2026-02-03-AZ].
Posture
Mixed
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-07-23.
What can break
High recent operating momentum may already be partly reflected in the share price.
Momentum
21
Value
57
Sentiment
66
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $212.00 · Bull $228.00 · Bear $176.00
Earnings
2026-07-23
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-15 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $217.80
Why
Momentum21 · Δ7d +5.7
Value57 · Δ7d -0.1
Sentiment66 · Δ7d -6.3
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
21
26% active weight
Current posture
7d trendImproving
Δ7d
+5.7
Δ21d
+9.6
Value
57
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.1
Sentiment
66
34% active weight
Current posture
7d trendSoftening
Δ7d
-6.3
Δ21d
-7.8
Why this grade
Composite grade C. Momentum 20.9 / Value 57.0 / Sentiment 66.1
Fundamentals (TTM)As of 2026-07-15
Fundamentals (TTM)
As of 2026-07-15
Market Cap
$9.78B
Beta
0.88
Shares Out
58.45M
P/E (TTM)
31.6
P/S (TTM)
2.12
P/FCF (TTM)
28.55
Rev YoY
+18.4%
EPS YoY
+21.9%
Gross Margin
+13.8%
Op Margin
+8.3%
Net Debt
$1.63B
Current Ratio
1.56
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology